Adrenergic blockers and the risk for common solid cancers: a case-control study.
Laboratory studies suggest adrenergic blockers may inhibit the proliferation and migration of cancer cells, but epidemiological evidence of their effect on cancer incidence has proved inconsistent. We therefore conducted a case-control study using the Clinical Practice Research Datalink to assess the effect of adrenergic blockers upon incidence of prostate, lung, bowel and breast cancer.
Amongst patients aged 18 years or older contributing at ...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher copy:
- Copyright date: